Multi-level microbial biology in the light of evolution
ESPID Education, Fernando Baquero, 179619
DESCRIPTION OF PREVALENCE OF SYMPTOMS RELATED ZIKA VIRUS IN PREGNANT WOMEN WITH CHILDREN WITH MICROCEPHALY DURING THE FIRST YEAR OF EPIDEMIC IN PERNAMBUCO/BRAZIL
ESPID Education, Luiza Mello, 179617
Zika
ESPID Education, Karin Nielsen, 179616
Dengue
ESPID Education, Elisabeth Barnett, 179615
Chinkungunya
ESPID Education, Marco Safadi, 179614
INCREASING VACCINE COVERAGE - BARRIERS AND ATTITUDES
ESPID Education, Robb Butler, 134427
GETTING VACCINATED - ACCESS AND ATTITUDES
ESPID Education, Irina Ljungqvist, 134426
COMPARISON OF CHILDREN TESTING NEGATIVE AND POSITIVE FOR EBOLA VIRUS DISEASE IN EBOLA HOLDING UNITS, SIERRA LEONE
ESPID Education, Felicity Fitzgerald, 132227
VACCINE HESITANCY - THE EMERGENCE OF GLOBAL MISUNDERSTANDING
ESPID Education, Emilie Karafillakis, 134428
REFUGEES ARRIVING IN EUROPE: THE MUNICH PAEDIATRIC INFECTION EXPERIENCE
ESPID Education, Ulrich von Both, 132230
TO LP OR NOT TO LP: SAFETY OF LUMBAR PUNCTURE IN COMATOSE CHILDREN WITH CLINCIAL FEATURES OF CEREBRAL MALARIA
ESPID Education, Christopher Moxon, 132229
RTSS MALARIA VACCINE., DOES IT WORK? IS IT SAFE?
ESPID Education, Brian Greenwood, 132228
INFLUENZA VACCINATION IN CHILDREN WITH CYSTIC FIBROSIS USING INTRANASAL LIVE ATTENUATED INFLUENZA VACCINE: EXPERIENCE FROM AN AUSTRIAN PAEDIATRIC HOSPITAL
ESPID Education, Sabine Renner, 132223
USING SMS TECHNOLOGY FOR REAL-TIME SURVEILLANCE OF ADVERSE EVENTS FOLLOWING IMMUNISATION
ESPID Education, Darren Westphal, 132226
MEASUREMENT OF FEVER AFTER INFANT IMMUNISATIONS: COMPARISON OF INTERMITTENT AND 24 HOURS CONTINUOUS MONITORING
ESPID Education, Marta Valente Pinto, 132225
EXPLORING INCIDENCE RATES OF GUILLIAIN BARR
ESPID Education, Jozica Skufca, 132224
NO ASSOCIATION OF THE TEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV10) WITH PREVIOUSLY SUGGESTED PCV SAFETY SIGNALS
ESPID Education, Arto A Palmu, 132222
ENHANCING VACCINE SAFETY CAPACITY GLOBALLY: A LIFECYCLE PERSPECTIVE
ESPID Education, Robert Chen, 132221
HIGHLIGHTS & LESSONS FROM THE FIRST 17 YEARS OF THE BRIGHTON COLLABORATION
ESPID Education, Jan Bonhoeffer, 132220
NASOPHARYNGEAL BACTERIAL DENSITY IS INCREASED BY VIRAL RESPIRATORY INFECTIONS WHICH MAY FACILITATE TRANSMISSION
ESPID Education, Valtyr Thors, 132219
DEXAMETHASONE FOR PLEURAL INFECTION IN CHILDREN: A DOUBLE BLIND, RANDOMIZED, CLINICAL TRIAL OF EFFICACY AND SAFETY
ESPID Education, ALFREDO TAGARRO, 132218
DIAGNOSIS AND PATHOPHYSIOLOGY OF BIOFILM INFECTIONS IN CYSTIC FIBROSIS
ESPID Education, Niels Hoeiby, 132217
SEASONAL AND PANDEMIC INFLUENZA IN PAEDIATRIC INTENSIVE CARE UNITS IN ENGLAND AND WALES: RISK FACTORS FOR ADMISSION AND MORTALITY
ESPID Education, Pia Hardelid, 132216
RSV - NEW THERAPEUTIC HORIZONS BRING CLINICAL CHALLENGES
ESPID Education, Steve Cunningham, 132215
THE RESURGENCE OF PERTUSSIS: FACTS, FICTION, MYTHS AND MISCONCEPTIONS?
ESPID Education, James Cherry, 132214
BILL MARSHALL LECTURE & AWARD: INTRODUCTION
ESPID Education, Adam Finn, 135835
ESCAPETB PROJECT -ENVIRONMENTAL SURVEILLANCE IN CANADA AND CAPE TOWN - IMPROVING OUR UNDERSTANDING OF AIRBORNE PATHOGEN EXPOSURE WITH A FOCUS ON TRANSMISSION OF ROD-SHAPED (MYCO-)BACTERIA)
ESPID Education, Koen Vanden Driessche, 132208
DISCOVERY OF IMMUNODOMINANT B CELL EPITOPES WITHIN SURFACE PNEUMOCOCCAL VIRULENCE PROTEINS IN PEDIATRIC PATIENTS WITH INVASIVE PNEUMOCOCCAL DISEASE
ESPID Education, Theano Lagousi, 132206
IMMUNOGENICITY OF REDUCED DOSE PRIMING SCHEDULES OF SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE FOLLOWED BY BOOSTER AT 12 MONTHS IN INFANTS: OPEN LABEL RANDOMISED CONTROLLED TRIAL
ESPID Education, David Pace, 132205
HOW DOES THE GUT-MICROBIOTA INFLUENCE THE ONSET AND NATURE OF JUVENILE IDIOPATHIC ARTHRITIS?
ESPID Education, Paula Sanchez-Moreno, 132203
PROTECTING AGAINST THE CHANGELING DEMON AND THE TROLL OF TRANSPLANTATION
ESPID Education, Stanley Plotkin, 132199
EARLY ANTIRETROVIRAL THERAPY PRESERVES THYMIC OUTPUT IN CHILDREN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS: EVIDENCE FROM THE CHILDREN WITH HIV EARLY ANTIRETROVIRAL THERAPY (CHER) TRIAL
ESPID Education, Helen Payne, 132198
ZIKA VÍRUS AND GESTATION: FIRST CASES DETECTED IN SERGIPE
ESPID Education, Eitan Berezin, 132197
PREVENTING EBOLA - THE RING VACCINATION STUDY
ESPID Education, Ana Maria Henao-Restrepo, 132187
IS IMMUNISING CHILDREN REALLY THE BEST WAY TO PROTECT THE ELDERLY AGAINST FLU?
ESPID Education, Marc Baguelin, 132194
UNIVERSAL CHILDHOOD VARICELLA VACCINE - MODELLING AND ETHICAL CONSTRUCTS
ESPID Education, Philippe Beutels, 132195
POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF TEICOPLANIN IN NEONATES
ESPID Education, Virginia Ramos Martin, 132193
PHARMACOMETRIC MODELS AND IN SILICO STUDIES
ESPID Education, Marc Pfister, 132192
PHARMACOKINETIC (PK) MODELLING OF MEROPENEM IN PLASMA AND CEREBROSPINAL FLUID (CSF) IN INFANTS WITH LATE-ONSET SEPSIS (LOS) AND/OR BACTERIAL MENINGITIS
ESPID Education, Eva Germovsek, 132190
A PRACTICAL GUIDE TO GETTING THE DOSE RIGHT
ESPID Education, Roger Brüggemann, 132189
NEUROLOGICAL AND AUTOIMMUNE COMPLICATIONS OF ZIKA VIRUS INFECTION
ESPID Education, Marco Safadi, 132188
CLINICAL SIGNS AND POINT OF CARE TESTING IN FEBRILE CHILDREN
ESPID Education, Henriette Moll, 132183
USING BIOMARKERS TO GUIDE MANAGEMENT IN THE EMERGENCY DEPARTMENT
ESPID Education, Alain Gervaix, 132182
EPIDEMIOLOGY AND VACCINE EFFECTIVENESS DURING A LARGE MUMPS OUTBREAK IN WESTERN AUSTRALIA
ESPID Education, Darren Westphal, 134425
CONTROL OF HIB IN CHILDREN: EPIDEMIOLOGY AND SEROPREVALENCE IN ENGLAND
ESPID Education, Sarah Collins, 134424
FEBRILE URINARY TRACT INFECTION DUE TO EXTENDED-SPECTRUM BETA-LACTAMASE-PRODUCING ENTEROBACTERIACEAE IN CHILDREN: AN OBSERVATIONAL FRENCH STUDY
ESPID Education, Fouad MADHI, 132179
ANTIBIOTIC PRESCRIPTION IN FEBRILE CHILDREN: IMPACT OF CLINICAL PROFILE AND CULTURAL BACKGROUND. A EUROPEAN OBSERVATIONAL STUDY IN EMERGENCY CARE.
ESPID Education, Rianne Oostenbrink, 132180
TOPICAL ANTIBIOTICS WORK!
ESPID Education, Roderick Venekamp, 132181
PRAGMATIC COMMUNITY ANTIMICROBIAL TRIALS IN CHILDREN AND ADULTS
ESPID Education, Paul Little, 132177
AN OVERVIEW OF GENETIC SUSCEPTIBILITY TO FUNGAL INFECTIONS
ESPID Education, Frank van de Veerdonk, 132176
MEROPENEM VS STANDARD OF CARE ANTIBIOTICS (SOC) FOR LATE ONSET NEONATAL SEPSIS (LOS): A RANDOMIZED CONTROLLED TRIAL NEOMERO-1
ESPID Education, Irja Lutsar, 132178
AN OVERVIEW OF GENETIC SUSCEPTIBILITY TO VIRAL INFECTIONS
ESPID Education, Vanessa Sancho-Shimizu, 132175
UNRAVELLING THE GENETICS OF MENINGOCOCCAL DISEASE: THE FACTOR H STORY REVISITED
ESPID Education, Sonia Maria Davila Dominguez, 132174
Diagnostics in a Digital Age: A Paediatric Perspective
ESPID Education, Rosanna Peeling, 132173
ADVANCES IN PATHOGEN DETECTION
ESPID Education, Mark Nicol, 132172
PROSPECTIVE VALIDATION OF LIPOCALIN-2 AS A PREDICTOR OF BACTERIAL INFECTION IN CHILDREN: A HOSPITAL-BASED STUDY.
ESPID Education, Climent Casals-Pascual, 132170
ACTIVATION OF THE INNATE IMMUNE SYSTEM AND ITS IMPLICATIONS FOR TREATMENT IN INFECTIOUS DISEASES
ESPID Education, Bruce Beutler, 132166
GENETIC INSIGHT INTO THE PERSISTENCE OF VACCINE-INDUCED IMMUNITY FOLLOWING CHILDHOOD IMMUNISATION
ESPID Education, Daniel O'connor, 132168
WHAT HAS THE RARE TAUGHT US ABOUT THE COMMON?
ESPID Education, Steven Holland, 132167
ESPID OPENING SYMPOSIUM - SHAPING THE FUTURE OF ANTIMICROBIAL AND VACCINE RESEARCH AND DEVELOPMENT
ESPID Education, Faculty / Presenters, 136517
HOST-PARASITE INTERACTIONS IN RELATION TO NUTRITIONAL STATUS AND THE IMPLICATIONS FOR THE WIDER SCIENTIFIC COMMUNITY
ESPID Education, Donald Bundy, 132160
MECHANISMS OF VIRAL VIRULENCE IN RESPONSE TO HUMAN NUTRITION
ESPID Education, Melinda Beck, 132159
MICAFUNGIN ALTERS THE AMINO ACID, NUCLEIC ACID, AND CENTRAL CARBON METABOLOMIC PROPERTIES OF CANDIDA ALBICANS AT SUBINHIBITORY CONCENTRATIONS: NOVEL INSIGHTS INTO MECHANISMS OF ACTION
ESPID Education, Aspasia Katragkou, 132161
INFECTION AND NUTRITION
ESPID Education, Alan Jackson, 135833
Q&A and panel discussion
ESPID Education, Faculty / Presenters, 141280
Is It Reasonable To Fear A Vaccine-Preventable Disease?
ESPID Education, Federico Martinón-Torres, 141279
The Public Health Authority: Perspective And Recommendations
ESPID Education, David Salisbury, 141278
Current Trends In Meningococcal Disease Epidemiology Around The Globe In The Genomic Surveillance Era
ESPID Education, Marco Safadi, 141277
Welcome and Session Objectives
ESPID Education, David Salisbury, 141276
PREVENTION OF ANTIMICROBIAL RESISTANCE IN THE CLINIC
ESPID Education, Jan A.J.W. Kluytmans, 99555
MECHANISMS OF ANTIMICROBIAL RESISTANCE
ESPID Education, Pentti Huovinen, 99551
Pertussis? a never ending story?
ESPID Education, Ulrich Heininger, 99548
Chair
ESPID Education, Adam Finn, 99547
The effects of LAIV on bacterial colonisation of the nasopharynx in young healthy children: A randomised controlled study
ESPID Education, Thors Valtyr, 99546
Preventive Therapy for Child Contacts of Multidrug-Resistant Tuberculosis: A Prospective Cohort Study
ESPID Education, James James, 99545
Lumpers versus splitters in Streptococcus pyogenes classification: Impact on vaccine development and molecular typing
ESPID Education, Pierre Smeesters, 99544
ESPID Fellowship Award 2015 Ceremony - Dynamics of Streptococcus pneumoniae colonization in children with acute otitis media -A modern analysis with whole genome sequencing
ESPID Education, Paula Tähtinen, 99542
ESPID Fellowship Award 2015 Ceremony - Circulating antibody-secreting cells (ASCs) during Mycoplasma pneumonia pneumonia in childhood: role in pathogenesis and diagnosis?
ESPID Education, Patrick M. Meyer Sauteur, 99541
ESPID Fellowship Award 2015 Ceremony - Understanding macrophage regulatory pathways in infant vulnerability to tuberculosis
ESPID Education, Anu Goenka, 99543
Chair
ESPID Education, Adam Finn, 99538
ESPID Distinguished Award for Education & Communication 2015 - "Drawing out and sharing"
ESPID Education, Andrew Pollard, 99539
GENETIC AND CLINICAL ASPECTS OF NTM INFECTIONS
ESPID Education, Philipp Henneke, 99524
CLOSTRIDIUM DIFFICILE -ASSOCIATED DISEASE IN CHILDREN
ESPID Education, Theoklis Zaoutis, 99528
TREATMENT OF MDR-PATHOGENS IN CHILDREN
ESPID Education, Shai Ashkenazi, 99529
HEPATITIS B
ESPID Education, Stefan Wirth, 99532
HEPATITIS C
ESPID Education, Giuseppe Indolfi, 99533
EVIDENCE BASED TREATMENT FOR SEPSIS IN NEONATES
ESPID Education, David Isaacs, 99536
Evidence of adjuvant therapies in bacterial meningitis
ESPID Education, Tobias Tenenbaum, 99537
INTERFERON-GAMMA RELEASE ASSAYS FOR THE DIAGNOSIS OF TUBERCULOUS AND NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
ESPID Education, Marc Tebruegge, 99525
Manipulating the Microbiome to Prevent HAIs
ESPID Education, Aaron Milstone, 99521
Antimicrobial stewardship in paediatric infectious diseases: the Spanish perspective
ESPID Education, Olaf Neth, 99519
SKIN INFECTIONS THROUGH PETS
ESPID Education, Simon Dobson, 99516
ATOPIC ECZEMA AND THE MICROBIOME
ESPID Education, Arnold Oranje, 99514
Predictors of Vaccine Response in Children
ESPID Education, Tobias Kollmann, 99511
RISE AND FALL OF NOROVIRUS
ESPID Education, Marion Koopmans, 99508
VACCINES OF THE FUTURE
ESPID Education, Vega Masignani, 99504
ACCELERATING CLINICAL TRIALS FOR NEW VACCINE DEVELOPMENT
ESPID Education, Adrian Hill, 99503
WEST-NILE-VIRUS IN CHILDREN
ESPID Education, Byron Martina, 99500
TICK-BORNE ENCEPHALITIS IN CHILDREN
ESPID Education, Jochen Süss, 99499
LYME DISEASE
ESPID Education, Franc Strle, 99498

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings